Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
Aulos develops an immune-activating monoclonal antibody therapeutic for cancer, using AI to design an antibody targeting the IL-2 portion that interacts with the CD25 receptor to shift IL-2 activity toward immune activation. Its lead investigational candidate, imneskibart, is in a Phase 1/2 clinical trial for solid tumor cancers including melanoma and renal cell carcinoma.
0 investors
0 investors
0 investors
Aurora Pharmaceutical is a pharmaceutical company whose site references veterinary care, indicating a focus on animal health products and treatments. The page provides only legal terms of use, so details on specific products are limited.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Auxergen is an agricultural biotechnology R&D company developing biological treatments such as CitriPhage for citrus canker, bio-treatments for Olive Quick Decline Syndrome, and bioremediation and phage-based technologies. It operates within the University of Maryland incubator system and serves agriculture, human health, and environmental sustainability markets, with international operations including a subsidiary in Bari, Italy.
0 investors
Auxilium Biotechnologies develops regenerative medicine devices, including the NeuroSpan Bridge, an implantable device to aid peripheral nerve regeneration. The company also works on in-space biomanufacturing, having demonstrated 3D bioprinting of implantable medical devices in microgravity aboard the ISS.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Avenacy develops and supplies sterile injectable medications for pharmacists and patients, with packaging and labeling designed to reduce administration errors and dosing mistakes. It operates in the pharmaceutical industry with a focus on injectable drug products.
0 investors
0 investors
Avenzoar Pharmaceuticals is a pharmaceutical company developing therapies through its team of scientists and researchers. The page provides team information but limited detail on specific products or focus areas.
0 investors
Aveta Biomics develops cancer therapeutics based on Orthologous Molecular Structures (OMS), metabolites from organisms with orthologous genes and processes, combined using an evolutionary-biology-based platform. Its drugs aim to treat and prevent cancers while addressing tumor heterogeneity and drug resistance.
0 investors
BioCentury provides news, analysis, and data covering the biotechnology and pharmaceutical industries.
0 investors
0 investors
0 investors